Thromboxane inhibition during concurrent therapy with low-dose aspirin and over-the-counter naproxen sodium.

about

Thromboxane inhibition during concurrent therapy with low-dose aspirin and over-the-counter naproxen sodium.

Item

http://www.wikidata.org/entity/Q49343433

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Thromboxane inhibition during ...... r-the-counter naproxen sodium.

@en

Thromboxane inhibition during ...... r-the-counter naproxen sodium.

@nl

type

Item

label

Thromboxane inhibition during ...... r-the-counter naproxen sodium.

@en

Thromboxane inhibition during ...... r-the-counter naproxen sodium.

@nl

prefLabel

Thromboxane inhibition during ...... r-the-counter naproxen sodium.

@en

Thromboxane inhibition during ...... r-the-counter naproxen sodium.

@nl

P1476

Thromboxane inhibition during ...... r-the-counter naproxen sodium.

@en

P2093

Emanuel Troullos

http://www.w3.org/2001/XMLSchema#string

Junhong Zhu

http://www.w3.org/2001/XMLSchema#string

Kevin P Bliden

http://www.w3.org/2001/XMLSchema#string

Palak Venkataraman

http://www.w3.org/2001/XMLSchema#string

Paul A Gurbel

http://www.w3.org/2001/XMLSchema#string

Robert Centofanti

http://www.w3.org/2001/XMLSchema#string

Sistine Jarvis

http://www.w3.org/2001/XMLSchema#string

Udaya S Tantry

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects

Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects

Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events

Double-blind, randomized, parallel, placebo-controlled study of ibuprofen effects on thromboxane B2 concentrations in aspirin-treated healthy adult volunteers

Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study

Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage.

Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Comparison of antiplatelet activity of microencapsulated aspirin 162.5 Mg (Caspac XL), with enteric coated aspirin 75 mg and 150 mg in patients with atherosclerosis.

Combination antithrombotic therapies.

Impact of a fixed-dose combination of naproxen and esomeprazole magnesium on serum thromboxane B2 inhibition by low-dose aspirin over 5 days in healthy adults: a phase I, randomized, double-blind, placebo-controlled, noninferiority trial.

P2888

s11239-017-1593-y

P304

18-26

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11239-017-1593-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29198079

http://www.w3.org/2001/XMLSchema#string